Investors
Sofinnova Partners
https://sofinnovapartners.comSofinnova Partners is a Paris-based venture capital firm investing from seed to later growth stages. They focus on biotech, health tech, and robotics, supporting early to late-stage companies with varying check sizes. Their portfolio includes Bioptimus, Cure51, and Moon Surgical. Sofinnova Partners aims to foster technological advancements and innovation in life sciences and deep tech sectors.
Recent Investments
- AsceneuronSeries C(
48 ) - May HealthSeries B( 52 )
- Disco PharmaceuticalsSeed( 41 )
- BioptimusSeed( 52 )
- Cure51Seed( 44 )
- Myricx BioSeries A( 75 )
- Alia TherapeuticsSeed( 26 )
- deepcSeries A( 41 )
- BioCorteXSeed( 37 )
- CorWaveSeries C( 52 )
- Tenpoint TherapeuticsSeries A( 48 )
- BrightHeartSeed( 37 )
- TissiumSeries D( 60 )
- Moon SurgicalSeries B( 60 )
- KiroSeries A( 44 )
- Sitryx TherapeuticsSeries A( 41 )
- Bon VivantSeries A( 41 )
- Noema PharmaSeries B( 48 )
- Gradient Denervation TechnologiesSeries A( 44 )
- Amolyt PharmaSeries C( 48 )
- SensorionSeries B( 41 )
- MicrophytUnknown( 33 )
- Mablink BioscienceSeries A( 41 )
- F2GUnknown( 48 )
- BiosyntiaSeries B( 37 )
- Moon SurgicalSeries A( 60 )
- GFBiochemicalsSeries A( 37 )
- Elicit PlantSeries A( 33 )
- TissiumSeries C( 60 )
- NorthSea TherapeuticsSeries C( 56 )
- Muna TherapeuticsSeries A( 52 )
- SafeHealUnknown( 52 )
- Mainstay MedicalUnknown( 56 )
- Mnemo TherapeuticsSeries A( 60 )
- GlycoEraSeries A( 44 )
- Micropep TechnologiesSeries A( 33 )
- SynthaceSeries C( 52 )
- Noema PharmaUnknown( 48 )
- NorthSea TherapeuticsSeries B( 56 )
- EnginZymeSeries A( 48 )
- Moon SurgicalSeed( 60 )
- AlediaSeries D( 48 )
- Myricx PharmaSeed( 44 )
- TissiumSeries B( 60 )
- May HealthSeries A( 52 )
- AFYX TherapeuticsUnknown( 41 )
- Sphere FluidicsUnknown( 26 )
- AFYX TherapeuticsSeries A( 41 )
- ENYO PharmaSeries A( 52 )
- MISSION TherapeuticsSeries C( 48 )
- MISSION TherapeuticsSeries B( 48 )
- TissiumSeries A( 60 )
- MISSION TherapeuticsSeries A( 48 )
- Mainstay MedicalSeries A( 56 )